| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 129.50B | — |
| Operating expense | — | — |
| Net income | 17.00B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DPM.F returned -10.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -38.8% |
| 1 year | -10.6% |
| 5 years | -5196.0% |
| 10 years | +91590058761.9% |
| All-time high | €29.69 (Nov 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in DPM.F would be worth today ›No. Sumitomo Pharma Co., Ltd. has not paid a dividend in the past 12 months.
Sumitomo Pharma Co., Ltd. is part of the Healthcare sector.
Sumitomo Pharma Co., Ltd. has a market cap of 3.43B EUR, based on the latest quote.
Sumitomo Pharma Co., Ltd. is scheduled to report earnings on Oct 30, 2026.
